Background The enlarged cysts in autosomal dominant polycystic kidney disease (ADPKD)
frequently cause abdominal discomfort. Cyst sclerotherapy with minocycline hydrochloride …

To reduce renal cyst size in autosomal dominant polycystic kidney disease (ADPKD),
minocycline hydrochloride solution was instilled into the enlarged cysts in three ADPKD …

Autosomal dominant polycystic kidney disease (ADPKD) is a common systemic genetic
disease which comprises 8 to 10% of patients treated by dialysis and transplantation …

Purpose: To provide a summary of the relevant literature regarding the impact of surgical
cyst decortication on hypertension, renal function, and pain management in patients with …

The weight of evidence gathered from studies in humans with hereditary polycystic kidney
disease (PKD) 1 and PKD2 disorders, as well as from experimental animal models …

Management of cystic kidney disease currently is restricted to relief of symptoms and control
of complications. There is presently no specific treatment that will reduce cyst formation in …

Autosomal dominant polycystic kidney disease (ADPKD) is considered the most common
inherited form of kidney disease across all ethnic types (1-3). Present understanding holds …

Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic disease
characterized by massive enlargement of fluid‐filled cysts in the kidney. Due to its genetic …

Autosomal dominant polycystic disease (ADPKD) is one of the most common monogenic
disorders, and globally is the third most common cause of endstage kidney disease. Until …

Autosomal-dominant polycystic kidney disease (ADPKD) is an inherited disorder usually
manifest in adulthood. It is characterized by the development of multiple renal cysts variably …